• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS CREP2; ENZYMATIC METHOD, CREATININE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS CREP2; ENZYMATIC METHOD, CREATININE Back to Search Results
Catalog Number 05168589190
Device Problem Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/20/2023
Event Type  malfunction  
Manufacturer Narrative
The serial number of the c702 analyzer is (b)(6).The investigation is ongoing.
 
Event Description
The initial reporter stated they received a questionable result for one patient sample tested with crep2 on a cobas 8000 c702 module.The patient sample initially resulted in a negative value for creatinine on the c702 analyzer.An interference was suspected and a serial dilution of the sample was performed using water and a creatinine result of 30 umol/l was obtained on the c702 analyzer.The patient sample was sent to another laboratory where an unknown creatinine jaffe method was used, resulting in a creatinine value of 56 umol/l.The customer performed a polyethylene glycol (peg) precipitation of the sample and repeated on the c702 analyzer and the creatinine result was 50 umol/l.
 
Manufacturer Narrative
The last calibration performed on (b)(6) 2023 was ok.Quality controls recovered within range.A general reagent issue can be ruled out since calibration and qc data are acceptable.The patient had a high igm result of 17.55 g/l.Per product labeling, "in very rare cases, gammopathy, in particular type igm (waldenström¿s macroglobulinemia), may cause unreliable result." the investigation could not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CREP2
Type of Device
ENZYMATIC METHOD, CREATININE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250
MDR Report Key17577898
MDR Text Key321558620
Report Number1823260-2023-02707
Device Sequence Number1
Product Code JFY
UDI-Device Identifier04015630924998
UDI-Public04015630924998
Combination Product (y/n)Y
Reporter Country CodeSN
PMA/PMN Number
K024098
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 09/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/18/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2023
Device Catalogue Number05168589190
Device Lot Number71018001
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/04/2023
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age91 YR
Patient SexFemale
-
-